X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-29-2023-93363.pdf
https://www.prnewswire.com/news-releases/xelstrym-dextroamphetamine-transdermal-system-cii-to-be-revealed-as-available-soon-at-the-2023-american-professional-society-of-adhd-and-related-disorders-apsard-conference-301717624.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-7-2022-68481.pdf
https://www.prnewswire.com/news-releases/noven-to-participate-in-annual-international-conference-on-adhd-chadd-301674128.html
https://www.prnewswire.com/news-releases/noven-to-present-poster-data-at-the-american-academy-of-child-and-adolescent-psychiatry-aacap-and-canadian-academy-of-child-and-adolescent-psychiatry-cacap-conference-301645992.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-6-2022-1657105109.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf
https://www.businesswire.com/news/home/20210427005959/en/Noven-to-Present-Pivotal-Study-Results-for-Investigational-Dextroamphetamine-Transdermal-System-for-Pediatric-ADHD-Patients
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-10-2021-1615353629.pdf
Market Place
Share 
